Evidence map›Paper›PMID 24178247›Full record

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

HIV/hepatitis C virus-coinfected patients and cirrhosis: how to diagnose it and what to do next?

Valérie Martel-Laferrière, Michael Wong, Douglas T Dieterich

Open access · bronzeAbstract readReview
PubMed Publisher
In one paragraph

Review in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Management of Hepatitis C/HIV Coinfection in the Era of Highly Effective Hepatitis C Virus Direct-Acting Antiviral Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2016
    Review
  2. Article
  3. The forgotten component in the staging and management of HIV/hepatitis C virus-coinfected patients.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Valérie Martel-LaferrièreDépartement de Microbiologie et Infectiologie, Centre Hospitalier de l'Université de Montréal, Quebec, Canada.
Michael Wong
Douglas T Dieterich
Beth Israel Deaconess Medical Center · USCentre Hospitalier de l’Université de Montréal · CAIcahn School of Medicine at Mount Sinai · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver disease, specifically cirrhosis, is a leading cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected patients. The diagnosis of early cirrhosis in HIV/hepatitis C virus (HCV)-coinfected patients may be challenging. The development of noninvasive methods for fibrosis assessment empowers the infectious disease specialist to diagnose advanced fibrosis or cirrhosis. Early diagnosis is essential to enroll patients in screening programs for esophageal varices and hepatocellular carcinoma. Cirrhosis may also modify decisions about treatment of both HIV and HCV, including vaccination, medications chosen, and referral for liver transplant.

Indexed as

CoinfectionHepatitis CHIV InfectionsHumansLiver CirrhosisLiver Neoplasmscirrhosishepatocellular carcinomaHIV/HCV coinfectionliver failurevarices

Identifiers

PMID24178247
OpenAlexW2149091463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.